Related Experiment Video
Updated: May 31, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Molecular mechanisms of altered bile acid homeostasis in organic solute transporter-alpha knockout mice
Tian Lan1, Jamie Haywood, Anuradha Rao
1Department of Internal Medicine, Section on Gastroenterology, Wake Forest University School of Medicine, Winston-Salem, N.C., USA.
Background/Aims:
Mutations in the apical sodium-dependent bile acid transporter (SLC10A2) block intestinal bile acid absorption, resulting in a compensatory increase in hepatic bile acid synthesis. Inactivation of the basolateral membrane bile acid transporter (OSTα-OSTβ) also impairs intestinal bile acid absorption, but hepatic bile acid synthesis was paradoxically repressed. We hypothesized that the altered bile acid homeostasis resulted from ileal trapping of bile acids that act via the farnesoid X receptor (FXR) to induce overexpression of FGF15. To test this hypothesis, we investigated whether blocking FXR signaling would reverse the bile acid synthesis phenotype in Ostα null mice.
Methods:
The corresponding null mice were crossbred to generate OstαFxr double-null mice. All experiments compared wild-type, Ostα, Fxr and OstαFxr null littermates. Analysis of the in vivo phenotype included measurements of bile acid fecal excretion, pool size and composition. Hepatic and intestinal gene and protein expression were also examined.
Results:
OstαFxr null mice exhibited increased bile acid fecal excretion and pool size, and decreased bile acid pool hydrophobicity, as compared with Ostα null mice. Inactivation of FXR reversed the increase in ileal total FGF15 expression, which was associated with a significant increase in hepatic Cyp7a1 expression.
Conclusions:
Inactivation of FXR largely unmasked the bile acid malabsorption phenotype and corrected the bile acid homeostasis defect in Ostα null mice, suggesting that inappropriate activation of the FXR-FGF15-FGFR4 pathway partially underlies this phenotype. Intestinal morphological changes and reduced apical sodium-dependent bile acid transporter expression were maintained in Ostα(-/-)Fxr(-/-) mice, indicating that FXR is not required for these adaptive responses.
Insights
Blocking the farnesoid X receptor (FXR) in mice with impaired bile acid transport corrected bile acid homeostasis. This suggests FXR signaling contributes to bile acid malabsorption phenotypes.
Area of Science:
- Hepatology and Gastroenterology
- Molecular Biology
- Metabolic Diseases
Background:
- Mutations in bile acid transporters disrupt intestinal absorption, leading to altered bile acid homeostasis.
- Inactivating the basolateral bile acid transporter (OSTα-OSTβ) impairs absorption but paradoxically represses hepatic bile acid synthesis.
- Ileal bile acid trapping via farnesoid X receptor (FXR) and FGF15 signaling is hypothesized to cause this repression.
Purpose of the Study:
- To investigate the role of FXR signaling in the bile acid homeostasis defect observed in Ostα null mice.
- To determine if blocking FXR signaling can reverse the repressed hepatic bile acid synthesis phenotype.
Main Methods:
- Generation of OstαFxr double-null mice by crossbreeding Ostα null and Fxr null mice.
- Comparison of wild-type, Ostα null, Fxr null, and OstαFxr double-null littermates.
- Analysis of bile acid fecal excretion, pool size, composition, and gene/protein expression in liver and intestine.
Main Results:
- OstαFxr null mice showed increased fecal bile acid excretion and pool size, with reduced pool hydrophobicity compared to Ostα null mice.
- FXR inactivation reversed increased ileal FGF15 expression.
- Significant increase in hepatic Cyp7a1 expression was observed following FXR inactivation.
Conclusions:
- Blocking FXR signaling largely corrected the bile acid homeostasis defect in Ostα null mice, unmasking the malabsorption phenotype.
- Inappropriate activation of the FXR-FGF15-FGFR4 pathway contributes to the observed phenotype.
- FXR is not required for adaptive intestinal morphological changes or reduced apical sodium-dependent bile acid transporter expression.
Related Concept Videos
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Hepatic Drug Clearance: Role of Transporters
ABC Transporters: Exporter
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...

